Alnylam Pharmaceuticals (ALNY) Q1 2017 Earnings

8FebConfirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-1.37
-1.26
-1.16
-1.05

Details

Expected EPS
-1.37
Actual EPS
-1.32
Surprise EPS
0.05
Surprise Percent
+3.65%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.32 per share for Q1 2017.

0 Comments

Share your thoughts